Determinants of resource utilization in four palliative care units

Palliative Medicine

Volumn 20, Issue 2, 2006, Pages 95-106

  Tibi Lévy, Yaël ^a,b   Le Vaillant, Marc ^a   de Pouvourville, Gérard ^a  

^a Centre de Recherche en Economie et Gestion Appliquée à la Santé CREGAS   (France)

^b INSERM   (France)

Author keywords

Costs; Financing; Hospital; Palliative care

Indexed keywords

ANXIETY; ARTICLE; BUDGET; CORRELATION ANALYSIS; COST BENEFIT ANALYSIS; DEATH; FAMILY ATTITUDE; HEAD AND NECK CANCER; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE UTILIZATION; HOSPITALIZATION; LENGTH OF STAY; MULTIVARIATE ANALYSIS; PALLIATIVE THERAPY; PATIENT ATTITUDE; PATIENT CARE; PATIENT SELECTION; PHYSICAL DISABILITY; PREDICTION; PROSPECTIVE STUDY; STANDARDIZATION;

AGED; COSTS AND COST ANALYSIS; FEMALE; FINANCING, ORGANIZED; FRANCE; HEALTH RESOURCES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PALLIATIVE CARE; PROSPECTIVE STUDIES;

EID: 33645785297     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269216306pm1110oa     Document Type: Article

References (53)

1. Fetter RB, Shin YS, Freeman JL, et al. Casemix definition by diagnosis-related group. Med Care 1980; 18: 1-53.
2. Vladeck BC. Medicare hospital payment by diagnosis-related groups. Ann Intern Med 1984; 100: 576-91.
3. Kimberly JR, de Pouvourville G. The migration of managerial innovation, diagnosis related groups and health care administration in western Europe. Jossey-Bass Publishers, 1992.
4. Mc Ginnis GE, Osberg S, Dejong G, et al. Predicting charges for inpatient medical rehabilitation using serverity, DRG, age and function. AJPH 1987; 77: 826-29.
5. Batavia AL, Dejong G. Prospective payment for medical rehabilitation: The DHHS report to Congress. Arch Phys Med Rehabil 1988; 69: 61-93.
6. Eagar K, Cromwell D, Kennedy C, et al. Classifying sub-acute and non-acute patients: Results of the New South Wales Case-mix Area Network Study. Aust Health Rev 1997; 20: 26-42.
7. Ministère de la Santé, de la Famille et des Personnes Handicapées, Mission Tarification à l'activité. Hôpital 2007, La tarification à l'activité, modèle d'allocation des resources et modalités de mise en œvre. 2003.
8. Cassel C, Vladeck B. ICD-9 code for palliative or terminal care. N Engl J Med 1996; 335: 1232-34.
9. Mahoney J. A new diagnosis-related group for palliative care. N Engl J Med 1996; 336: 1029-30.
10. Ministère de l'emploi et de la solidarité. PMSI Soins de Suite et de Readaptation, version 1 de la classification, version 1.1 de la fonction groupage. Manuel des Groupes Homogènes de Journées, Bulletin officiel no 97/8 bis., 1997.
11. Ministère de la santé, de la famille et des personnes handicapées, Direction de l'Hospitalisation et de l'Organisation des Soins. Programme de medicalisation des systèmes d'information en soins de suite et réadaptation, etude nationale de coûts - PMSI SSR, exploitation du premier semestre 2000 relative aux établissements de santé sous dotation globale. 2003.
12. Schaerer R, Desforges E, Laval G. Comment évaluer les coûts des soins palliatifs? J d'Econ Méd 1991; 9: 7-18.
13. Maltoni M, Travaglini C, Santi M, et al. Evaluation of the cost of home care for terminally ill cancer patients. Support Care Cancer 1997; 5: 396-401.
14. Hill F, Oliver C. Hospice - an update on the cost of patient care. Health Trends 1998; 20: 83-86.
15. Belasco JB, Danz P, Drill A, et al. Supportive care: Palliative care in children, adolescents, and young adults - model of care, interventions, and cost of care: A retrospective review. J Palliat Care 2000; 16: 39-46.
16. Guest JF, Hart WM, Cookson RF. Cost analysis of palliative care for terminally ill cancer patients in the UK after switching from weak to strong opioids. Palliative Care Advisory Committee. Pharmacoeconomics 1998; 14: 285-97.
17. Twycross R, Fallon M, Sharma K, et al. L'effet des choix therapeutiques sur le coût total des soins palliatifs. Eur J Palliat Care 1999; 6: 94-97.
18. Witteveen PO, van Groenestijn MA, Blijham GH, et al. Use of resources and costs of palliative care with parenteral fluids and analgesics in the home setting for patients with end-stage cancer. Ann Oncol 1999; 10: 161-65.
19. Ross JR, Saunders Y, Cochrane M, et al. A prospective, within-patient comparison between metal butterfly needles and Teflon cannulae in subcutaneous infusion of drugs to terminally ill hospice patients. Palliat Med 2002; 16: 13-16.
20. Dallal HJ, Smith GD, Grieve DC, et al. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 2001; 54: 549-57.
21. Glimelius B, Hoffman K, Graf W, et al. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol 1995; 6: 267-74.
22. Bloom BS. Is hospice care least expensive for the terminally ill? Hosp J 1987; 3: 67-76.
23. Kane RL, Wales J, Bernstein L, et al. A randomised controlled trial of hospice care. Lancet 1984; 1: 890-94.
24. Dunt DR, Cantwell AM, Temple-Smith. The cost-effectiveness of the City Mission Hospice Programme, Melbourne. Palliat Med 1989; 3: 125-34.
25. Birnbaum HG, Kidder D. What does hospice cost? Am J Public Health 1984; 74: 689-97.
26. Mor V, Kidder D. Cost savings in hospice: Final results of the National Hospice Study. Health Serv Res 1985; 20: 407-22.
27. Greer DS, Mor V, Morris JN, et al. An alternative in terminal care: Results of the National Hospice Study. Chronic Dis 1986; 39: 9-26.
28. Spector WD, Mor V. Utilization and charges for terminal cancer patients in Rhode Island. Inquiry 1984; 21: 328-37.
29. Hannan EL, O'Donnell JF. An evaluation of hospices in the New York State Hospice Demonstration Program. Inquiry 1984; 21: 338-48.
30. Gomez-Batiste X, Fontanals MD, Roca J, et al. Catalonia WHO demonstration project on palliative care implementation 1990-1995: Results in 1995. J Pain Symptom Manage 1996; 12: 73-78.
31. Axelsson B, Christensen SB. Evaluation of a hospital-based palliative support service with particular regard to financial outcome measures. Palliat Med 1998; 12: 41-49.
32. Bloom BS, Kissick PD. Home and hospital cost of terminal illness. Med Care 1980; 18: 560-64.
33. Serra-Prat M, Gallo P, Picaza JM. Home palliative care as a cost-saving alternative: Evidence from Catalonia. Palliat Med 2001; 15: 271-78.
34. Uys L, Hensher M. The cost of home-based terminal care for people with AIDS in South Africa. S Afr Med J 2002; 92: 624-28.
35. Raftery JP, Addington-Hall JM, MacDonald LD, et al. A randomized controlled trial of the cost-effectiveness of a district co-ordinating service for terminally ill cancer patients. Palliat Med 1996; 10: 151-61.
36. Addington-Hall JM, MacDonald LD, Anderson HR, et al. Randomised controlled trial of effects of coordinating care for terminally ill cancer patients. BMJ 1992; 305: 1317-22.
37. Barrau A. Humaniser la mort, est-ce ainsi que les hommes meurent? Un scénario pour la France. L'Harmattan Collection Logiques Sociales, 1993.
38. Kidder D. The effects of hospice coverage on Medicare expenditures. Health Serv Res 1992; 27: 195-217.
39. Emanuel EJ, Emanuel LL. The economics of dying. The illusion of cost savings at the end of life. N Engl J Med 1994; 330: 540-44.
40. Le Divenah A. Résultats de l'enquête nationale sur les structures de soins palliatifs existant en France (au 31 Décembre 2004), Colloque: Le développement des soins palliatifs et de l'accompagnement - Bilan du Programme National 2002-2005 et perspectives, Paris, 8 December, 2005.
41. Tibi-Lévy Y, D'Hérouville D. Présentation d'un outil descriptif de l'activité palliative hospitalière: Le CODAP. Med Palliat 2003; 2: 136-47.
42. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In Macleod CM ed. Evaluation of chemotherapeutic agents. Columbia University Press, 1949: 191-205.
43. Yates J, Chalmer B, McKeney P. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980; 45: 2220-24.
44. Union des Caisses Nationales de Sécurité Sociale. Nomenclature générale des actes professionnels. Nomenclature des actes de biologie bédicale. 2000.
45. Fédération des Etablissements Hospitaliers et d'Assistance Privés à But non Lucratif (FEHAP). Convention collective nationale du 31 Octobee 1951. Extended by the decree of 27 Février 1961, revised version October 1998.
46. Ministère de l'Emploi et de la Solidarité. Les soins palliatifs en Ile-de-France. Compte-rendu résumé de la Table Ronde organisée par la DRASS d'Ile-de-France dans le cadre des Etats Généraux de la Santé, 1998.
47. Burucoa B. Concept de souffrance globale. Unité de soins palliatifs. Centre Hospitalier Universitaire de Bordeaux.
48. Richard MS. La souffrance globale. In Manuel de soins palliatifs. Dunod, 2001.
49. De Beir C. La phase ultime. In Manuel de soins palliatifs. Dunod, 2001.
50. Tebbit P. New funding arrangements for specialist PC services. Retrieved from http://www.mccn.nhs.uk/documents/ PeterTebbit-presentation.ppt (Accessed 2nd March 2006).
51. Tibi-Lévy Y, D'Hérouville D. Etude prospective multi-centrique sur la prise en charge de patients hospitalisés et suivis par une équipe de soins palliatifs. Med Palliat 2004; 3: 6-18.
52. Tibi-Lévy Y, D'Hérouville D. Developing an operational typology of patients hospitalised in PC units. Palliat Med 2004; 18: 248-58.
53. er Mars 2005, relative à la campagne tarifaire 2005 des établissements de santé antérieurement financés par dotation globale, 2005.